Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Wagner

Showing results (141-150 of 174) with videos related to

Pageof 18
Sort By:
Gastroenterology|March 9, 2026
Prevalence and Consequences of APC Mosaicism in Patients With Colorectal AdenomasDiantha Terlouw, Manon Suerink, Yentl Buitelaar, et al.
American Journal of Human Genetics|March 27, 2003
Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 geneAnja Wagner, Alicia Barrows, Juul Th Wijnen, et al.
American Journal of Human Genetics|April 12, 2003
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotypeHanne Meijers-Heijboer, Juul Wijnen, Hans Vasen, et al.
Gastroenterology|June 15, 2015
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1Rachel S van der Post, Ingrid P Vogelaar, Peggy Manders, et al.
Gastroenterology|July 6, 2004
Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillanceYvonne M C Hendriks, Anja Wagner, Hans Morreau, et al.
Genes, Chromosomes & Cancer|May 9, 2024
Delineating genotype and parent-of-origin effect on the phenotype in MSH6-associated Lynch syndromeAnne-Sophie van der Werf-'t Lam, Mar Rodriguez-Girondo, Mandy Villasmil, et al.
Familial Cancer|March 21, 2020
Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillanceKasper A Overbeek, Djuna L Cahen, Anne Kamps, et al.
Journal of Medical Genetics|June 5, 2010
TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypesMarielle W G Ruijs, Senno Verhoef, Matti A Rookus, et al.
Plos One|June 15, 2016
Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome PatientsAnne M L Jansen, Marije A Geilenkirchen, Tom van Wezel, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2025
Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationwide prospective cohort studyGaby J Strijk, Jelle C van Dongen, Willem de Koning, et al.
Pageof 18

Showing results (141-150 of 174) with videos related to

Sort By:
Pageof 18
Gastroenterology|March 9, 2026
Prevalence and Consequences of APC Mosaicism in Patients With Colorectal AdenomasDiantha Terlouw, Manon Suerink, Yentl Buitelaar, et al.
American Journal of Human Genetics|March 27, 2003
Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 geneAnja Wagner, Alicia Barrows, Juul Th Wijnen, et al.
American Journal of Human Genetics|April 12, 2003
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotypeHanne Meijers-Heijboer, Juul Wijnen, Hans Vasen, et al.
Gastroenterology|June 15, 2015
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1Rachel S van der Post, Ingrid P Vogelaar, Peggy Manders, et al.
Gastroenterology|July 6, 2004
Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillanceYvonne M C Hendriks, Anja Wagner, Hans Morreau, et al.
Genes, Chromosomes & Cancer|May 9, 2024
Delineating genotype and parent-of-origin effect on the phenotype in MSH6-associated Lynch syndromeAnne-Sophie van der Werf-'t Lam, Mar Rodriguez-Girondo, Mandy Villasmil, et al.
Familial Cancer|March 21, 2020
Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillanceKasper A Overbeek, Djuna L Cahen, Anne Kamps, et al.
Journal of Medical Genetics|June 5, 2010
TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypesMarielle W G Ruijs, Senno Verhoef, Matti A Rookus, et al.
Plos One|June 15, 2016
Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome PatientsAnne M L Jansen, Marije A Geilenkirchen, Tom van Wezel, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2025
Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationwide prospective cohort studyGaby J Strijk, Jelle C van Dongen, Willem de Koning, et al.
Pageof 18